Risk stratification in hospitalized COVID-19 patients.
作者信息
Horvath Angela, Lind Theresa, Frece Natalie, Wurzer Herbert, Stadlbauer Vanessa
机构信息
Divison of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria; Center for Biomarker Research in Medicine (CBmed), Graz, Austria.
Divison of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
出版信息
J Hepatol. 2021 Sep;75(3):740-742. doi: 10.1016/j.jhep.2021.04.024. Epub 2021 Apr 24.
Abstract
摘要
相似文献
1
Risk stratification in hospitalized COVID-19 patients.住院COVID-19患者的风险分层
J Hepatol. 2021 Sep;75(3):740-742. doi: 10.1016/j.jhep.2021.04.024. Epub 2021 Apr 24.
2
Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.三级护理医院中新冠病毒肺炎住院患者重症风险因素评估
J Assoc Physicians India. 2021 May;69(5):56-61.
3
Clinical outcome, risk assessment, and seasonal variation in hospitalized COVID-19 patients-Results from the CORONA Germany study.COVID-19 住院患者的临床结局、风险评估和季节性变化——来自德国 CORONA 研究的结果。
PLoS One. 2021 Jun 17;16(6):e0252867. doi: 10.1371/journal.pone.0252867. eCollection 2021.
4
Patients' treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections.患者的治疗限制作为 COVID-19 患者死亡的预测因素：来自 SARS-CoV-2 感染热点地区住院患者的结果。
Respir Res. 2021 Jun 4;22(1):168. doi: 10.1186/s12931-021-01756-2.
5
Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.针对需要住院治疗的 COVID-19 退伍军人的激素干预（HITCH）：一项多中心、2 期随机对照试验，比较最佳支持治疗与最佳支持治疗加地加瑞克：一项随机对照试验的研究方案。
Trials. 2021 Jul 5;22(1):431. doi: 10.1186/s13063-021-05389-0.
6
Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk tool.美国住院 COVID-19 患者短期死亡率预测风险模型的开发和外部验证：COVID-AID 风险工具的建议。
PLoS One. 2020 Sep 30;15(9):e0239536. doi: 10.1371/journal.pone.0239536. eCollection 2020.
7
Presepsin in risk stratification of SARS-CoV-2 patients.血清淀粉样蛋白 P 组分在 SARS-CoV-2 患者危险分层中的作用。
Clin Chim Acta. 2020 Aug;507:161-163. doi: 10.1016/j.cca.2020.04.020. Epub 2020 Apr 22.
8
"For COVID" or "With COVID": Classification of SARS-CoV-2 Hospitalizations in Children.“因 COVID”或“有 COVID”：儿童中 SARS-CoV-2 住院的分类。
Hosp Pediatr. 2021 Aug;11(8):e151-e156. doi: 10.1542/hpeds.2021-006001. Epub 2021 May 19.
9
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.SARS-CoV-2 特异性抗体分泌细胞的扩增和住院 COVID-19 患者中中和抗体的产生。
J Immunol. 2020 Nov 1;205(9):2437-2446. doi: 10.4049/jimmunol.2000717. Epub 2020 Sep 2.
10
Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection.住院的轻症/普通型 COVID-19 患者中，SARS-CoV-2 核酸检测转阴时间延长患者的临床特征。
BMC Infect Dis. 2021 Feb 3;21(1):141. doi: 10.1186/s12879-021-05851-z.
引用本文的文献
1
Editorial: COVID-19: From bedside to follow-up.社论：2019冠状病毒病：从床边到随访
Front Med (Lausanne). 2023 Feb 22;10:1155049. doi: 10.3389/fmed.2023.1155049. eCollection 2023.
2
Validation of a simple risk stratification tool for COVID-19 mortality.一种用于预测COVID-19死亡风险的简易分层工具的验证
Front Med (Lausanne). 2022 Oct 11;9:1016180. doi: 10.3389/fmed.2022.1016180. eCollection 2022.
3
Hematological changes associated with COVID-19 infection.与 COVID-19 感染相关的血液学变化。
J Clin Lab Anal. 2022 Jan;36(1):e24064. doi: 10.1002/jcla.24064. Epub 2021 Nov 16.
Zotero 插件